EFPIA - NEWSLETTER

EFPIA Newsletter 17 June 2021

New Presidency team at EFPIA

Yesterday, the EFPIA General Assembly confirmed Hubertus von Baumbach (Chairman of the Board of Managing Directors at Boehringer Ingelheim) as President of EFPIA for the next two years. The General Assembly also confirmed Novo Nordisk President and CEO, Lars Fruergaard Jørgensen as First Vice-president of EFPIA for the same term. Mr Olivier Laureau, President of Servier, completes the new presidency team at EFPIA as Second Vice President. Read the press release here.

Watch the video message from Hubertus von Baumbach here:

News

15 June 2021 The pharmaceutical industry: a key asset to medical progress and the European economy

The Pharmaceutical Industry in Figures 2021

15 June 2021 EFPIA response to EPSCO discussion on access to medicines and medical devices for a stronger...

Three steps to faster more equitable access to therapies in Europe

From our blog

17 June 2021 Unlocking the potential of the European Health Data Space to improve diabetes management in...

The COVID-19 pandemic in particular has revealed the extent with which diabetes is intertwined with other social determinants,...

17 June 2021 Regulatory Pathways for an Integral Drug-Device Combination Product Platform based on Quality...

Using a platform approach in the development of an integral drug-device combination product provides an opportunity...

14 June 2021 Can partnerships help boost vaccine supply?

An interview with Dr Steffen Lang, Global Head of Novartis Technical Operations and member of the Executive Committee...

11 June 2021 EFPIA Connecting Healthcare Awards – it’s all about how collaboration brings people together...

Every project for patients would deserve an award for the effort, for coming together to realize an idea to help patients....

Videos

Unlocking the power of health data: the promise of the European Health Data Space

A virtual event hosted by EFPIA and MedTech Europe

Five steps to urgently advance COVID-19 vaccine equity

A call from innovative vaccine manufacturers and biotech companies

Events

18 JUN 2021

The Animal Welfare Body - a catalyst for progress Virtual Event

A meeting convened by EFPIA and the RSPCA, with input from FELASA and EFAT

Learn more →

24 JUN 2021

AMR: how can we prevent the next pandemic? Virtual event

An EFPIA virtual event

Learn more →

25 JUN 2021

Beating cancer: Looking ahead, learning from the past Virtual event

The Impact of COVID-19 on Patient Access to Cancer Care in Europe

Learn more →

29 JUN 2021

How can COVID-19 treatments help us on the road to recovery? Virtual event

An EFPIA virtual event

Learn more →

What we are reading

Value-based Vaccination: What's the Cost of Non-vaccination for Public Health? 16 June 2021 (Eventbrite)

Health systems after COVID-19 – Building resilience through a value-based approach 08 June 2021 (European Alliance for Value in Health)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶